Highfine(301393.SZ)

The core logic of this round of bull market: "AI technology moves downstream, while exports and overseas expansion move upstream."

The core logic of this round of bull market lies in the downward movement of AI technology and the upward movement of exports. The main index has broken through 4034 points, and the market is generally bullish, with expectations for upward space in the main index by 2026. Currently, attention should be paid to the transition of liquidity and fundamentals, as well as the logic of the year-end market rally. The small and mid-cap indices are performing strongly and will transition towards the four major pillars, emphasizing the co-dance of new and old industries, especially the breakthroughs in AI applications and the transformation of traditional industries

China tightens regulations on dual-use items to resolutely curb Japan's militaristic ambitions

In January 2026, China will implement strict export controls on dual-use items to Japan, prohibiting all relevant items from being exported to Japanese military users, and launching an anti-dumping investigation into the import of dichlorodihydrosilane from Japan. This control covers over 900 items and involves multiple industrial chains, aiming to respond to the remarks of Japanese Prime Minister Fumio Kishida and the militarization trends of Japanese right-wing forces, safeguarding national security and interests

China Sulphates Market Business Report 2025 provides insights on market with analysis and trade data. - ResearchAndMarkets.com.

A recent report titled "Sulphates Market in China: Business Report 2025" has been included in ResearchAndMarkets.com's offerings. This report provides an analysis of the sulphates market in China, offering insights into various aspects such as domestic production, consumption, and future market projections. The report includes a brief country profile outlining general information, key economic indicators, and the business environment in China. Additionally, the analysis covers trade statistics and forecasts for market expansion.

The innovative drug concept surged in the afternoon, with Nossan hitting the 20% limit up, followed by gains in PR, Tigermed, Jiuzhou Pharma, and Highfine

Highfine released its performance for the first three quarters, with a net profit attributable to the parent company of 99.2383 million yuan, an increase of 3.01%

Highfine released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 435 million yuan, a year-on-year increase of 32.47%. The net profit attributable to the parent company was 99.2383 million yuan, a year-on-year increase of 3.01%. The net profit after deducting non-recurring gains and losses was 81.272 million yuan, a year-on-year decrease of 2.79%. The basic earnings per share were 0.93 yuan